Increased Risks Of Lower-Limb Amputations For Farxiga And Jardiance
During late August a presentation at the 2018 European Society of Cardiology Congress in Munich, Germany included evidence that the SGLT-2 inhibitors Invokana, Jardiance, and Farxiga all are associated...
View ArticleInvokana / Jardiance / Farxiga: Increased Risk Of Pancreatitis, According To...
Health Canada’s safety review of sodium-glucose cotransporter-2 (SGLT2) inhibitors — e.g., Invokana (canagliflozin), Farxiga (dapagliflozin), and Jardiance (empagliflozin) — concluded in July 2018 with...
View ArticleFournier’s Gangrene: Side Effect For Invokana, Farxiga, And Jardiance
From this August 29, 2018 Drug Safety Communication, “FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes”, we get the following details about...
View ArticleAmputations Are Diabetes Drugs Side Effects For SGLT2 Inhibitors Class
There seems to be an increasing degree of acknowledgement in the medical literature that these lower limb amputations are drug-class side effects of SGLT2 inhibitor diabetes medicines such as Jardiance...
View ArticleFarxiga And Jardiance Have Two-Time Increased Risk For Amputations
Patients using the diabetes drugs Farxiga and Jardiance had twice the risk for lower limb amputations relative to certain other diabetes medicines, according to a new observational study published in...
View ArticleLower Limb Amputations From All SGLT2 Inhibitors, or Just Invokana?
A “Black-Box Warning” about the increased risk of lower limb amputations was added to the drug labels for Invokana and Invokamet in July 2017. Since that time there has been a mix of opinions expressed...
View ArticleCases Of Fournier Gangrene Associated With Diabetes Drugs Invokana,...
The FDA has identified 55 unique cases of Fournier gangrene associated with diabetes drugs in the Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors class between March 1, 2013 and January 31, 2019. Of...
View ArticleQuestions Raised About Whether Fournier’s Gangrene Is A Side Effect Of...
At the recent American Diabetes Association (ADA) Scientific Sessions there were reportedly questions raised about whether there is an increased risk of Fournier’s gangrene when using Farxiga as well...
View ArticleSGLT2 Inhibitors Invokana, Farxiga, Jardiance Linked to Retinal Vein Occlusion
Since being approved by the FDA as diabetes drugs years ago, Invokana, Farxiga, and Jardiance — as well as Invokamet, Xigduo, Glyxambi, Synjardy, Qtern, Steglatro, Steglujan, Segluromet, and other...
View ArticleDrug Injury Lawsuits: List of Some Cases Filed in First Half of 2021
A drug injury lawsuit is a personal injury case or a wrongful death case involving a serious drug side effect or a severe adverse drug reaction. Here are some of the prescription medications for which...
View Article